ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Sunday, November 8, 2015

9:00AM-11:00AM
Abstract Number: 521
Targeted Quantitative Analysis to Identify Citrullinated Peptides in the Synovial Fluid of Patients with Rheumatoid Arthritis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I
9:00AM-11:00AM
Abstract Number: 535
Taurine As a Biomarker for Prediction of Response to Biologic Therapy in Rheumatoid Arthritis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I
9:00AM-11:00AM
Abstract Number: 305
The “Sleeve Sign”� in Dermatomyositis
Muscle Biology, Myositis and Myopathies Poster
9:00AM-11:00AM
Abstract Number: 96
The ABCG2 polymorphism Is Associated with Hyperuricemia in a Community-Based Korean Cohort
Genetics, Genomics and Proteomics Poster I
9:00AM-11:00AM
Abstract Number: 873
The ANCA-Vasculitis Index of Damage (AVID): Performance of a New Damage Instrument
Vasculitis Poster I
9:00AM-11:00AM
Abstract Number: 173
The Automated Software-Guided Ultrasound Assessment of Bilateral Common Carotids Intima-Media Thickness for Investigation of Cardiovascular Risk in Psoriasis:Comparison Between Patients with or without Arthritis
Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy
9:00AM-11:00AM
Abstract Number: 355
The Clinical and Genetic Spectrum of Low Alkaline Phosphatase in Adults
Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster
9:00AM-11:00AM
Abstract Number: 537
The Course of Bone Marrow Edema in Early Undifferentiated and Rheumatoid Arthritis; A Longitudinal MRI Study on Bone Level
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I
9:00AM-11:00AM
Abstract Number: 28
The Decrease over Time of Orthopaedic Surgery in Patients with Rheumatoid Arthritis Is Mainly Due to Reduced Rates Among Those with Rheumatoid Factor Positive Disease – Results from a Well Defined Area
Epidemiology and Public Health Poster I: Comorbidities and Outcomes of Systemic Inflammatory Diseases
9:00AM-11:00AM
Abstract Number: 729
The Effect of Belimumab on Peripheral Blood Cells in Patients with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I
9:00AM-11:00AM
Abstract Number: 342
The Effect of Erosive Status on Systemic Inflammatory Biomarkers in Hand Osteoarthritis
Osteoarthritis - Clinical Aspects Poster I: Treatments and Metabolic Risk Factors
9:00AM-11:00AM
Abstract Number: 459
The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry
Rheumatoid Arthritis - Clinical Aspects Poster I
9:00AM-11:00AM
Abstract Number: 116
The Effect of the Formal Approval of Colchicine on Utilization of Emergency Department and Rheumatology Outpatient Services By Patients with Gout
Health Services Research Poster I: Diagnosis, Management and Treatment Strategies
9:00AM-11:00AM
Abstract Number: 368
The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital
Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis Poster
9:00AM-11:00AM
Abstract Number: 834
The Efficacy of Rituximab in Systemic Sclerosis Joint Disease: A Pilot Study
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I
  • «Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 73
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology